Out of stock

This item is currently unavailable

Gone for 65 days. Could come back at any time — we're watching for you.

Out of stock 65 days

World Outlook for Triple-Negative Breast Cancer Treatments

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

Get an industry perspective with The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments. Published by ICON Group International, Inc., this book provides specialized information regarding the landscape of cancer treatment developments through 2030. It serves as a targeted resource for those studying or working within the medical and pharmaceutical sectors. This publication offers a dedicated look at the global outlook for this specific area of oncology, making it a relevant addition to professional libraries and academic collections focused on medical subjects.

Key Features

This book covers the 2025-2030 world outlook for triple-negative breast cancer treatments.

The publication is produced by ICON Group International, Inc.

This resource is categorized under medical subjects for professional study.

The text focuses on the global landscape of cancer treatment developments.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
04 April 2024

Similar Products You Might Like

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
99% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 03 Nov 2026
World Outlook for Breast Cancer Diagnostic Products 2025-2030
98% match

World Outlook for Breast Cancer Diagnostic Products 2025-2030

Price unavailable
World Outlook for Breast Cancer Screenings 2025-2030
98% match

World Outlook for Breast Cancer Screenings 2025-2030

Price unavailable
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
98% match

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Price unavailable
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
97% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 26 Sep 2026
US Breast Cancer Diagnostic Products Outlook 2023-2028
97% match

US Breast Cancer Diagnostic Products Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
2023-2028 US Breast Cancer Screening Outlook Study
97% match

2023-2028 US Breast Cancer Screening Outlook Study

£520.00 07 Nov 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook India
97% match

HER-2 Positive Breast Cancer Chemotherapy Outlook India

£515.00 07 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 02 Oct 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
97% match

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

£520.00 04 Nov 2026
India Breast Cancer Diagnostic Products Outlook 2023-2028
97% match

India Breast Cancer Diagnostic Products Outlook 2023-2028

£515.00 05 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 26 Sep 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
97% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 31 Oct 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
97% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 02 Nov 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
97% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 03 Nov 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
97% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 02 Nov 2026
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
97% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 04 Nov 2026
The 2025-2030 World Outlook for Digital Breast Tomosynthesis
97% match

The 2025-2030 World Outlook for Digital Breast Tomosynthesis

Price unavailable
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
97% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 02 Oct 2026
The 2021-2026 World Outlook for Breast Biopsies
97% match

The 2021-2026 World Outlook for Breast Biopsies

Price unavailable
The 2023-2028 World Outlook for Digital Breast Tomosynthesis
97% match

The 2023-2028 World Outlook for Digital Breast Tomosynthesis

Price unavailable
The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies
97% match

The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies

£885.00 20 Oct 2026